Direct oral anticoagulants (DOACs)

被引：8
|
作者：
Vazquez, Sara [1 ]
Rondina, Matthew T. [2 ,3 ,4 ]
机构：
[1] Univ Utah, Hlth Sci Ctr, Univ Healthcare Thrombosis Serv, Salt Lake City, UT USA
[2] Univ Utah, Dept Internal Med, Div Gen Internal Med, Salt Lake City, UT 84112 USA
[3] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA
[4] George E Wahlen Salt Lake City VAMC, Dept Internal Med, Salt Lake City, UT USA
来源：
VASCULAR MEDICINE | 2015年 / 20卷 / 06期
关键词：
anticoagulants; apixaban; dabigatran; edoxaban; rivaroxaban; thrombosis; DVT; pulmonary embolism; PATIENT;
D O I：
10.1177/1358863X15600256
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
DOACs are a new group of blood-thinner medications that may have some advantages over warfarin. A health care provider will look at several different factors to help patients decide if a DOAC is a good choice. Patients taking DOACs should discuss medication changes, a plan for taking the DOAC before and after a surgery, and any bleeding side effects with their health care provider.
引用
下载
收藏
页码：575 / 577
页数：3
相关论文
共 50 条
  • [41] Evaluation of direct oral anticoagulants (DOACs) prescriptions in geriatric hospital over 3 years
    Nahornyj, Elsa
    Goutelle, Svlain
    Bourguignon, Laurent
    de la Gastine, Blandine
    THERAPIE, 2021, 76 (03): : 191 - 200
  • [42] Severity of Gastrointestinal Bleeding in Patients Treated With Direct-Acting Oral Anticoagulants (DOACS)
    Brodie, Mark M.
    Smith, Tyler
    Newman, Jill
    Rockey, Don C.
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB421 - AB422
  • [43] Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
    Maurizio Sessa
    Annamaria Mascolo
    Torbjörn Callréus
    Annalisa Capuano
    Francesco Rossi
    Morten Andersen
    Scientific Reports, 9
  • [44] Direct-acting Oral anticoagulants (DOACs) in pregnancy: New insight from VigiBase®
    Sessa, Maurizio
    Mascolo, Annamaria
    Callreus, Torbjorn
    Capuano, Annalisa
    Rossi, Francesco
    Andersen, Morten
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 384 - 385
  • [45] Management of severe bleeding due to direct oral anticoagulants (DOACs): apixaban, dagibatran, rivaroxaban
    Sagourin, Pauline
    Martelli, Sonia
    Lefebure, Anne
    Tesmoingt, Chloe
    Faille, Dorothee
    Ajzenberg, Nadine
    Casalino, Enrique
    Arnaud, Philippe
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 215 - 216
  • [46] Overview and Practical Application of Coagulation Assays in Managing Anticoagulation with Direct Oral Anticoagulants (DOACs)
    Rimsans J.
    Douxfils J.
    Smythe M.A.
    Gosselin R.C.
    Current Pharmacology Reports, 2020, 6 (5) : 241 - 259
  • [47] Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia
    Serrao, Alessandra
    Ballotta, Laura
    Dragoni, Francesco
    Pallotta, Agnese
    Chistolini, Antonio
    THROMBOSIS RESEARCH, 2020, 196 : 539 - 540
  • [48] Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
    Ferri, Nicola
    Colombo, Elisa
    Tenconi, Marco
    Baldessin, Ludovico
    Corsini, Alberto
    PHARMACEUTICS, 2022, 14 (06)
  • [49] Switch from vitamin k antagonists (vkas) to direct oral anticoagulants (DOACS): a pratical approach
    Pasca, S.
    Venturelli, U.
    Bertone, A.
    Barillari, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 392 - 392
  • [50] An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery
    Johnston, S.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2016, 45 (05) : 618 - 630
12345